Century Therapeutics SVP Finance Carr Douglas Sells 275 Shares

What Happened

• Carr Douglas, Senior Vice President of Finance & Operations at Century Therapeutics (IPSC), sold 275 shares on 2026-08-03 at $1.98 per share for gross proceeds of approximately $544. The filing indicates these sales were automatic to satisfy tax withholding on vested restricted stock units, not discretionary sales.

Key Details

• Transaction date: 2026-08-03
• Price per share: $1.98; Shares sold: 275; Gross proceeds: ≈ $544
• Method: Reported as open market or private sale; footnote F1 states the sale was automatic to cover tax withholding for RSU vesting
• Filing date: 2026-08-05 (filed promptly after the transaction)
• Shares owned after transaction: Not disclosed in the provided excerpt

Context

• This sale appears routine and related to tax-withholding obligations on vested RSUs rather than a voluntary, sentiment-driven disposition. Such automatic "sell-to-cover" transactions are common and generally not considered a strong signal about an insider's view of the company.